atai Life Sciences N.V. Beat Consensus Estimates
Wednesday, May 14, 2025 at 7:00 AM ET
atai Life Sciences N.V. (ATAI) reported a loss of $0.15 per share on revenue of $1.56 million for the first quarter ended March 2025. The consensus estimate was a loss of $0.19 per share on revenue of $1.50 million. The company beat consensus estimates by 21.05%.
atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders.
Earnings Whisper Grade
Power Rating
-
-
Reported Earnings
$-0.15
Earnings Whisper®
-
Consensus Estimate
$-0.19
Earnings Surprise
Earnings Growth
Reported Revenue
$1.55 Mil
Revenue Estimate
$1.50 Mil
Revenue Surprise
Revenue Growth